These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38130639)

  • 1. Crosstalk between gut microbiota and gut resident macrophages in inflammatory bowel disease.
    Zhang H; Wang X; Zhang J; He Y; Yang X; Nie Y; Sun L
    J Transl Int Med; 2023 Dec; 11(4):382-392. PubMed ID: 38130639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease.
    Ma S; Zhang J; Liu H; Li S; Wang Q
    Front Cell Dev Biol; 2022; 10():896591. PubMed ID: 35721513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages.
    Wang J; Chen WD; Wang YD
    Front Microbiol; 2020; 11():1065. PubMed ID: 32582063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage interactions with fungi and bacteria in inflammatory bowel disease.
    Leonardi I; Li X; Iliev ID
    Curr Opin Gastroenterol; 2018 Nov; 34(6):392-397. PubMed ID: 30239343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines.
    Kim J; Zhang S; Zhu Y; Wang R; Wang J
    J Ginseng Res; 2023 Sep; 47(5):627-637. PubMed ID: 37720571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet-Microbiota Interplay: An Emerging Player in Macrophage Plasticity and Intestinal Health.
    O'Mahony C; Amamou A; Ghosh S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut Microbiome and Inflammatory Bowel Diseases.
    Shan Y; Lee M; Chang EB
    Annu Rev Med; 2022 Jan; 73():455-468. PubMed ID: 34555295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gut Microbiota in Inflammatory Bowel Disease.
    Qiu P; Ishimoto T; Fu L; Zhang J; Zhang Z; Liu Y
    Front Cell Infect Microbiol; 2022; 12():733992. PubMed ID: 35273921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy.
    Pan X; Zhu Q; Pan LL; Sun J
    Pharmacol Ther; 2022 Oct; 238():108176. PubMed ID: 35346728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System.
    Yue B; Luo X; Yu Z; Mani S; Wang Z; Dou W
    Microorganisms; 2019 Oct; 7(10):. PubMed ID: 31614539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
    Tie Y; Huang Y; Chen R; Li L; Chen M; Zhang S
    Gut Microbes; 2023 Dec; 15(2):2265028. PubMed ID: 37822139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota.
    Hou JJ; Ma AH; Qin YH
    Front Cell Infect Microbiol; 2023; 13():1279172. PubMed ID: 37942478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome-phage interactions in inflammatory bowel disease.
    Federici S; Kviatcovsky D; Valdés-Mas R; Elinav E
    Clin Microbiol Infect; 2023 Jun; 29(6):682-688. PubMed ID: 36191844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of intestinal microbiota and metabolites in inflammatory bowel disease.
    Dong LN; Wang M; Guo J; Wang JP
    Chin Med J (Engl); 2019 Jul; 132(13):1610-1614. PubMed ID: 31090547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.
    Kim YS; Hurley EH; Park Y; Ko S
    Exp Mol Med; 2023 Jul; 55(7):1380-1387. PubMed ID: 37464092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.